Mark G. Hegarty

463 total citations
11 papers, 331 citations indexed

About

Mark G. Hegarty is a scholar working on Biophysics, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Mark G. Hegarty has authored 11 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biophysics, 5 papers in Molecular Biology and 2 papers in Analytical Chemistry. Recurrent topics in Mark G. Hegarty's work include Spectroscopy Techniques in Biomedical and Chemical Research (9 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Cell Image Analysis Techniques (3 papers). Mark G. Hegarty is often cited by papers focused on Spectroscopy Techniques in Biomedical and Chemical Research (9 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Cell Image Analysis Techniques (3 papers). Mark G. Hegarty collaborates with scholars based in United Kingdom, United States and Germany. Mark G. Hegarty's co-authors include Holly J. Butler, David Scott Palmer, Paul M. Brennan, Michael D. Jenkinson, Matthew J. Baker, James M. Cameron, Benjamin R. Smith, Timothy Dawson, Khaja Syed and Katherine M. Ashton and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Mark G. Hegarty

10 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark G. Hegarty United Kingdom 9 222 131 115 52 39 11 331
Christopher Rinaldi United Kingdom 12 254 1.1× 155 1.2× 170 1.5× 96 1.8× 26 0.7× 14 452
Hesham K. Yosef Germany 10 369 1.7× 225 1.7× 187 1.6× 84 1.6× 13 0.3× 16 523
Alexandra Sala United Kingdom 10 201 0.9× 127 1.0× 188 1.6× 82 1.6× 124 3.2× 16 464
Ewa Kaznowska Poland 15 396 1.8× 243 1.9× 249 2.2× 68 1.3× 32 0.8× 34 626
Damien Traynor Ireland 11 244 1.1× 181 1.4× 181 1.6× 52 1.0× 21 0.5× 17 372
Cerys A. Jenkins United Kingdom 9 138 0.6× 96 0.7× 67 0.6× 45 0.9× 8 0.2× 16 390
Chi Shu Singapore 11 124 0.6× 89 0.7× 98 0.9× 64 1.2× 27 0.7× 17 375
Mia R. Garrard United States 3 256 1.2× 103 0.8× 89 0.8× 132 2.5× 6 0.2× 3 355
Brandy Broadbent United States 4 297 1.3× 169 1.3× 117 1.0× 104 2.0× 5 0.1× 5 377

Countries citing papers authored by Mark G. Hegarty

Since Specialization
Citations

This map shows the geographic impact of Mark G. Hegarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Hegarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Hegarty more than expected).

Fields of papers citing papers by Mark G. Hegarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Hegarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Hegarty. The network helps show where Mark G. Hegarty may publish in the future.

Co-authorship network of co-authors of Mark G. Hegarty

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Hegarty. A scholar is included among the top collaborators of Mark G. Hegarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Hegarty. Mark G. Hegarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cameron, James M., Alexandra Sala, Γεώργιος Αντωνίου, et al.. (2023). A spectroscopic liquid biopsy for the earlier detection of multiple cancer types. British Journal of Cancer. 129(10). 1658–1666. 24 indexed citations
2.
Cameron, James M., Paul M. Brennan, Γεώργιος Αντωνίου, et al.. (2022). Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer. Neuro-Oncology Advances. 4(1). vdac024–vdac024. 15 indexed citations
3.
Baker, Matthew J., Alexandra Sala, Γεώργιος Αντωνίου, et al.. (2022). Multicancer early detection with a spectroscopic liquid biopsy platform.. Journal of Clinical Oncology. 40(16_suppl). 3034–3034. 1 indexed citations
4.
Cameron, James M., Holly J. Butler, Michael D. Jenkinson, et al.. (2021). Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer. International Journal of Technology Assessment in Health Care. 37(1). e41–e41. 10 indexed citations
5.
Brennan, Paul M., Holly J. Butler, Mark G. Hegarty, et al.. (2021). Early diagnosis of brain tumours using a novel spectroscopic liquid biopsy. Brain Communications. 3(2). fcab056–fcab056. 23 indexed citations
6.
Cameron, James M., Christopher Rinaldi, Holly J. Butler, et al.. (2020). Stratifying Brain Tumour Histological Sub-Types: The Application of ATR-FTIR Serum Spectroscopy in Secondary Care. Cancers. 12(7). 1710–1710. 27 indexed citations
7.
Cameron, James M., Christopher Rinaldi, Alexandra Sala, et al.. (2020). Interrogation of IDH1 Status in Gliomas by Fourier Transform Infrared Spectroscopy. Cancers. 12(12). 3682–3682. 10 indexed citations
8.
Cameron, James M., Holly J. Butler, Benjamin R. Smith, et al.. (2019). Developing infrared spectroscopic detection for stratifying brain tumour patients: glioblastoma multiforme vs. lymphoma. The Analyst. 144(22). 6736–6750. 35 indexed citations
9.
Butler, Holly J., Paul M. Brennan, James M. Cameron, et al.. (2019). Development of high-throughput ATR-FTIR technology for rapid triage of brain cancer. Nature Communications. 10(1). 4501–4501. 147 indexed citations
10.
Butler, Holly J., Ruth Board, Paul M. Brennan, et al.. (2018). Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios. BMJ Open. 8(5). e017593–e017593. 39 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Rinaldi Breakdown of academic impact, for papers by Hesham K. Yosef Breakdown of academic impact, for papers by Alexandra Sala Breakdown of academic impact, for papers by Ewa Kaznowska Breakdown of academic impact, for papers by Damien Traynor Breakdown of academic impact, for papers by Cerys A. Jenkins Breakdown of academic impact, for papers by Chi Shu Breakdown of academic impact, for papers by Mia R. Garrard Breakdown of academic impact, for papers by Brandy Broadbent
Rankless by CCL
2026